Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. neurotarget

NEUROTARGET SIGNED

Treatment of traumatic brain injury using dye-loaded polymeric nanoparticles

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NEUROTARGET project word cloud

Explore the words cloud of the NEUROTARGET project. It provides you a very rough idea of what is the project "NEUROTARGET" about.

sub    children    poloxamer188    specificity    technique    translation    release    action    techniques    leader    risk    udisco    therapeutics    biodegradable    body    mechanisms    drugs    blood    bright    traumatic    optimal    create    secondary    neuroprotective    visualization    clinical    co    nanoparticles    lactide    future    laboratory    vivo    extra    strategies    consequently    therapeutic    ultimately    drug    exact    subsequently    compounds    trying    distribute    running    potency    3d    innovative    disability    microscopy    treatment    np    platform    route    safe    barrier    combine    brain    multiple    treatments    unknown    obstacles    cutting    cross    tbi    gain    models    photon    cellular    locations    despite    adults    opportunity    carriers    thereby    combination    damage    inability    cells    urgently    glycolide    technologies    translational    intact    minimizing    host    penetration    coated    clearing    extensive    edge    injury    young    bbb    plga    synergistic    poly    treat    nano    cargo    giving   

Project "NEUROTARGET" data sheet

The following table provides information about the project.

Coordinator		 LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Total cost 171˙460 €
 EC max contribution 171˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 171˙460.00

Map

 Project objective

Traumatic brain injury (TBI) is the number one cause of disability in children and young adults. Despite well-known mechanisms of secondary brain damage after TBI, effective treatments have not been yet established. Consequently, novel strategies to develop therapeutics which have translational potential are urgently required. One of the major obstacles when trying to treat the brain is the inability of drugs to cross the blood-brain barrier (BBB). Therefore, it is of great importance to develop novel strategies of drug delivery to targeted locations across the intact BBB. Poly(lactide-co-glycolide) nanoparticles (PLGA NP) are safe and biodegradable drug carriers. When coated with poloxamer188, they are able to cross the BBB. However, the exact mechanisms of penetration, as well as their route to target cells in the brain are currently unknown. To investigate this, the applicant will combine three cutting-edge technologies: novel extra-bright PLGA NP, in vivo two-photon microscopy and whole body clearing (uDISCO). These techniques in combination allow 3D visualization at the sub-cellular level of how PLGA NP distribute throughout the body, cross the BBB and release their cargo in vivo. These NP will subsequently be used as carriers to deliver multiple neuroprotective compounds with synergistic action into the brain. This technique allows high specificity and potency of therapeutic compounds, while minimizing the risk of side effects. Ultimately, objective of this approach is to create an optimal novel nano-platform for brain-targeted drug-delivery and based on this, to provide an innovative treatment of TBI that has the potential for clinical translation. Furthermore, the project will enable the applicant to gain extensive knowledge in advanced in vivo microscopy and TBI models, techniques that are well established in the host laboratory, thereby giving him the opportunity to become a leader in this novel field of research running his own research unit in the future

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEUROTARGET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEUROTARGET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Widow Spider Mating (2020)

Immature mating as a novel tactic of an invasive widow spider

Read More  

TARGET SLEEP (2020)

Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease

Read More  

PIZERO_NA62 (2019)

Study of neutral pion decays at the NA62 experiment at CERN

Read More